Analysts’ View: VEON (VEON), ManTech (MANT), Biogen (BIIB)

Brokerage Firm Goldman upgraded VEON Ltd. (NASDAQ:VEON) shares from Neutral to Buy rating.

VEON Ltd., through its subsidiaries, provides mobile and fixed-line telecommunications services.


Investment Analysts at SunTrust upgraded ManTech International Corporation (NASDAQ:MANT) shares from Hold to Buy rating.

ManTech International Corporation provides technologies and solutions for mission-critical national security programs worldwide.


Biogen Inc. (NASDAQ:BIIB) shares were upgraded by analysts at Citigroup from Neutral to Buy rating.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at